Pilot implementation study of HIV Pre-Exposure Prophylaxis (PrEP) among People Who Inject Drugs (PWID)


The term of realization

16.12.2019 – 31.12.2020

05.01.2021 – 31.05.2021

20.12.2021 – 30.04.2022

Principal Investigator

Kostiantyn Dumchev

Funded by

ICF «Alliance for Public Health»

The aim of the project

Developing a new, more effective approach to preventing the spread of HIV among injecting drug users.

Goals and objectives

Primary Objectives
  • To compare adherence to and retention on daily PrEP prescribed as the fixed dose formulation to PWID randomized 1:1 to PrEP as usual or SMS-enhanced PrEP.
Secondary Objectives
  • To describe patterns and attributes of PrEP adherence among participants (e.g., SMS acceptance, substance use, sociocultural factors)
  • To measure changes in injection and sexual risk taking behavior among study participants
  • To describe client- and provider-level barriers to PrEP initiation and adherence.
Scroll to Top